RedDr. Introduces ArchPad Featuring Patented Six-Level Arch Support System

RedDr. introduces ArchPad, a medical-grade footcare product designed to reduce fatigue through a six-level customizable arch support system. The product recently reached a top 0.1% sales rank on Amazon in the Sports Accessories category.
RedDr., a South Korean health and wellness brand, has officially announced the launch of ArchPad, a next-generation insole featuring a patented six-level adjustable arch support system. On November 29, 2024, the product reached the top 0.1% rank on Amazon within the Sports Accessories category, representing a key milestone for its global expansion.

Image: https://www.globalnewslines.com/uploads/2025/07/bb13997b44b8191b47602667544cf238.jpg

Image: https://www.globalnewslines.com/uploads/2025/07/1cc3e25ae8a6bbe72ad2fde2aa3374fe.jpg

Designed to address chronic foot fatigue and structural imbalances, ArchPad targets one of the most widespread yet overlooked health concerns: poor foot posture and pain due to prolonged standing or walking. The ArchPad allows users to adjust both the height and firmness of the arch structure to suit flat feet, normal arches, or high arches, offering a tailored approach to foot alignment.

Unlike traditional insoles that merely provide cushioning, ArchPad delivers dynamic mid-foot stimulation with every step. This helps to activate foot muscles, realign body posture, and reduce inflammation caused by poor foot mechanics. The design is compatible with sneakers, casual shoes, and even slippers.

The product incorporates six core functional features:

1. Six-Level Adjustable Arch Support

Each ArchPad includes a patented modular support system with 6 removable arch inserts, allowing users to adjust both height and firmness to match their natural arch. This helps re-align the foot, ankle, knee, and hip for full-body posture correction.

Image: https://www.globalnewslines.com/uploads/2025/07/c2e5db291e9f1bdaa41d74f54efb77b5.jpg

2. Midfoot Stimulation Technology

Encourages circulation and relieves pain through targeted pressure on the medial arch.

3. Weight Redistribution

Design Relieves pressure from the heel and forefoot by elevating the arch and stabilizing the heel.

4. Antibacterial, Odor-Resistant Materials

EVA and mesh prevent bacterial growth for long-lasting freshness.

5. Endurance-Tested Durability

Withstands over 1 million flexes without losing shape or support.

6. Universal Fit and Adhesive Grip

Stays in place during daily wear in most types of footwear.

Image: https://www.globalnewslines.com/uploads/2025/07/b1f338f7169d4a621d26d3ee43f45a39.jpg

According to RedDr., more than 75% of adults begin to experience foot dysfunction by age 40. ArchPad aims to offer a proactive, accessible alternative to custom orthotics, which are often expensive and difficult to obtain.

"Our mission was to create a footcare product that combines science, comfort, and long-term durability," said Min Kyungjoon, CEO of RedDr.'s parent company, Dispis. "ArchPad is a reflection of our dedication to solving everyday health challenges with precision and innovation."

RedDr. ArchPad is currently available in international markets and has achieved notable success on Amazon and Rakuten Japan, where it ranked #1 in the insole category.
Media Contact
Company Name: Dispis Co., Ltd.
Contact Person: Min Kyungjoon
Email: Send Email [http://www.universalpressrelease.com/?pr=reddr-introduces-archpad-featuring-patented-sixlevel-arch-support-system]
Country: South Korea
Website: https://www.reddr.co.kr/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.